Rosiglitazone for prevention or adjuvant treatment of Nelson’s syndrome after bilateral adrenalectomy
Author(s) -
Mikkel Andreassen,
Lars Østergaard Kristensen
Publication year - 2005
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje.1.01994
Subject(s) - medicine , rosiglitazone , hyperpigmentation , adrenalectomy , endocrinology , magnetic resonance imaging , transsphenoidal surgery , hydrocortisone , morning , surgery , urology , adenoma , pituitary adenoma , diabetes mellitus , radiology , dermatology
To investigate the effect of Rosiglitazone in three patients treated with bilateral adrenalectomy followed by hyperpigmentation and hypersecretion of ACTH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom